212 related articles for article (PubMed ID: 32346549)
1. Development of Large-Scale Downstream Processing for Lentiviral Vectors.
Valkama AJ; Oruetxebarria I; Lipponen EM; Leinonen HM; Käyhty P; Hynynen H; Turkki V; Malinen J; Miinalainen T; Heikura T; Parker NR; Ylä-Herttuala S; Lesch HP
Mol Ther Methods Clin Dev; 2020 Jun; 17():717-730. PubMed ID: 32346549
[TBL] [Abstract][Full Text] [Related]
2. Insights into product and process related challenges of lentiviral vector bioprocessing.
Perry C; Mujahid N; Takeuchi Y; Rayat ACME
Biotechnol Bioeng; 2023 Aug; ():. PubMed ID: 37526313
[TBL] [Abstract][Full Text] [Related]
3. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.
Tran MY; Kamen AA
Front Bioeng Biotechnol; 2022; 10():887716. PubMed ID: 35774066
[TBL] [Abstract][Full Text] [Related]
4. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
[TBL] [Abstract][Full Text] [Related]
5. Process intensification for lentiviral vector manufacturing using tangential flow depth filtration.
Tona RM; Shah R; Middaugh K; Steve J; Marques J; Roszell BR; Jung C
Mol Ther Methods Clin Dev; 2023 Jun; 29():93-107. PubMed ID: 36994313
[TBL] [Abstract][Full Text] [Related]
6. Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced
Soldi M; Sergi Sergi L; Unali G; Kerzel T; Cuccovillo I; Capasso P; Annoni A; Biffi M; Rancoita PMV; Cantore A; Lombardo A; Naldini L; Squadrito ML; Kajaste-Rudnitski A
Mol Ther Methods Clin Dev; 2020 Dec; 19():411-425. PubMed ID: 33294490
[TBL] [Abstract][Full Text] [Related]
7. Depth filtration for clarification of intensified lentiviral vector suspension cell culture.
Mayani M; Nellimarla S; Mangalathillam R; Rao H; Patarroyo-White S; Ma J; Figueroa B
Biotechnol Prog; 2024; 40(2):e3409. PubMed ID: 37985144
[TBL] [Abstract][Full Text] [Related]
8. Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media.
Bauler M; Roberts JK; Wu CC; Fan B; Ferrara F; Yip BH; Diao S; Kim YI; Moore J; Zhou S; Wielgosz MM; Ryu B; Throm RE
Mol Ther Methods Clin Dev; 2020 Jun; 17():58-68. PubMed ID: 31890741
[TBL] [Abstract][Full Text] [Related]
9. Toward a Scalable Purification Protocol of GaLV-TR-Pseudotyped Lentiviral Vectors.
Boudeffa D; Bertin B; Biek A; Mormin M; Leseigneur F; Galy A; Merten OW
Hum Gene Ther Methods; 2019 Oct; 30(5):153-171. PubMed ID: 31516018
[TBL] [Abstract][Full Text] [Related]
10. Quasi-perfusion studies for intensified lentiviral vector production using a continuous stable producer cell line.
Stibbs DJ; Silva Couto P; Takeuchi Y; Rafiq QA; Jackson NB; Rayat ACME
Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101264. PubMed ID: 38827249
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral Vector Purification Using Nanofiber Ion-Exchange Chromatography.
Ruscic J; Perry C; Mukhopadhyay T; Takeuchi Y; Bracewell DG
Mol Ther Methods Clin Dev; 2019 Dec; 15():52-62. PubMed ID: 31649955
[TBL] [Abstract][Full Text] [Related]
12. Clinical grade lentiviral vector purification and quality control requirements.
Shi R; Jia S; Liu H; Nie H
J Sep Sci; 2022 Jun; 45(12):2093-2101. PubMed ID: 35247228
[TBL] [Abstract][Full Text] [Related]
13. Scaling Up of Steric Exclusion Membrane Chromatography for Lentiviral Vector Purification.
Labisch JJ; Paul R; Wiese GP; Pflanz K
Membranes (Basel); 2023 Jan; 13(2):. PubMed ID: 36837652
[TBL] [Abstract][Full Text] [Related]
14. Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.
Kutner RH; Puthli S; Marino MP; Reiser J
BMC Biotechnol; 2009 Feb; 9():10. PubMed ID: 19220915
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting.
Dasgupta A; Tinch S; Szczur K; Ernst R; Shryock N; Kaylor C; Lewis K; Day E; Truong T; Swaney W
Methods Mol Biol; 2020; 2086():27-60. PubMed ID: 31707666
[TBL] [Abstract][Full Text] [Related]
16. Scaleable purification process for gene therapy retroviral vectors.
Rodrigues T; Carvalho A; Carmo M; Carrondo MJ; Alves PM; Cruz PE
J Gene Med; 2007 Apr; 9(4):233-43. PubMed ID: 17428003
[TBL] [Abstract][Full Text] [Related]
17. Implementation of Novel Affinity Ligand for Lentiviral Vector Purification.
Moreira AS; Bezemer S; Faria TQ; Detmers F; Hermans P; Sierkstra L; Coroadinha AS; Peixoto C
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834764
[TBL] [Abstract][Full Text] [Related]
18. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
19. Downstream processing of lentiviral vectors: releasing bottlenecks.
Bandeira V; Peixoto C; Rodrigues AF; Cruz PE; Alves PM; Coroadinha AS; Carrondo MJ
Hum Gene Ther Methods; 2012 Aug; 23(4):255-63. PubMed ID: 22934827
[TBL] [Abstract][Full Text] [Related]
20. Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography.
Eglon MN; Duffy AM; O'Brien T; Strappe PM
J Gene Med; 2009 Nov; 11(11):978-89. PubMed ID: 19670285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
